{"name":"Pilatus Biosciences Inc","slug":"pilatus-biosciences-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxQbTNJUHJkOU9nOG96NEdycUlhcTdIeE5BNElFeDhJaTR6b0VmUkFIQkRZZloweVVzN1BrQXRYNzkxdXYxd0dvUjQ3cGpQNzZqYVZvVjlnZTZZb1p2a1JvMUpIb1VJSHRvaVRCWlEtMVRqQnlZV2VIdlo1M2RfRlRGOHUtdGd4b09ZZDdCSWZmU3RWd1RHdExEX0oxSE5fTEU0UDdKTWFfWnlVSF80cS1YOFlUNDAzb25meFF4NkY4OEFQUXZXS0t5R2hqX1VSSDNTVHhxQ2pnWTdBVjlncGdkQ2hVWGRhUXN4VjZaTTVxdkJhd29pWXZGX2xEZ041WFpLNVpWcHpn?oc=5","date":"2026-04-08","type":"trial","source":"BioSpace","summary":"Pilatus Biosciences to Present New Data Highlighting Sex-Specific Efficacy of CD36-Targeting Antibody in Colorectal Cancer at AACR 2026 - BioSpace","headline":"Pilatus Biosciences to Present New Data Highlighting Sex-Specific Efficacy of CD36-Targeting Antibody in Colorectal Canc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxORDJod1pnX0VQNkxvdkJDOXJHSG9UZHFVZktFdkpNajYxcEdmQ01salh1UzJ4ZzlQTXgxb1VyVXpzeWtUaEFVUFREeTdkdFFLM3NwT1Q0LXZNWTYxdnpzeU9aNmtjMFRleFRyLTlWZlJnRC1EamNvUDRITmJaNEtPM25qUllJZzFZaGdZRHJ1all4Y2U2a1BwOVdKNzRRTmMyQmdYME9EUGlPSDRwb2NRcnlNU3pmWHMtSVB0SS1SZGxYVjBZRTZ0Ym1ScnNGWUdyZTRNUVJCREhvaWtsbFF5bWhvSVlfalozWGFQVXNoSm4zUlg3azBuNUpqUzdGMHV1dEdiZHpCZ0g?oc=5","date":"2026-03-12","type":"trial","source":"BioSpace","summary":"Pilatus Biosciences Announces First Patient Dosed in Phase 1 Trial of First-in-Class Metabolic Checkpoint Antibody PLT012 in Solid Tumors - BioSpace","headline":"Pilatus Biosciences Announces First Patient Dosed in Phase 1 Trial of First-in-Class Metabolic Checkpoint Antibody PLT01","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPTjFuanFnZ0lpampJc0hyMEJCNFVrWG5pYnotQ0FfNkt3ZHh0c3U1WGxNRDZRUzNVakJzUkdtWTBZa0dlRF9IX29jbW9xYWI0bm9ZdmtLWFVIdE5CRnUxa0hGNzJwclk5UFhZeldGdlRmcnQwRU5vMWFwdko4SEwxYUozbUkwN3NoNW9uTk9RVU1Oc1VTU0RKUWtlc1d4T1NmVUFWUA?oc=5","date":"2026-03-02","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in February 2026 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in February 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNZ2Q4cDFVVjRhcy1CU09MS0ZIb21CVUNTTFNJSnAwM3BPcEVFMTdBOTBuWTVhTTBfa0xvNjhnV0J6T1hMOWl4YnFSRjBYOEVZaU9TNmMyME9tZVlmVWd4Q3IzWjhmQ3AyTUgxeUFCc3RtUFFleXVsTWJ2UTFwYnM1TXJ5RktYSzFnLTVha2hydGdNZHNaUGtLMHN5NFhmRC1UWEhOem0wbUtsWXJQLTFQbjRIa0k3SEdsQnBsbWdpZW15MWpQaDZlby1fU2JzazJ6MlE?oc=5","date":"2026-02-20","type":"pipeline","source":"Clinical Leader","summary":"Reprogramming The Tumor Microenvironment Bringing A Metabolic Checkpoint Therapy Into The Clinic - Clinical Leader","headline":"Reprogramming The Tumor Microenvironment Bringing A Metabolic Checkpoint Therapy Into The Clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxOYkFtMC1LNU02ZTVtd2YtYURBdWxsV1ZsalQ1dlhTcXpyNXVVNkllZXBmbFhLZkwyMWVjWGpRN2VoTXZ0VFI1akc4WXF2RTMtZl9HR2txLTFnVDMxNXY2bDVsZzdJRkNiTW5YTHF1cGhaTHVwUWlDWEV1Xy1PUDl6X2g1aGRQbFVvcmlXeVc3clNMeDRXY2hpcXpoRXBpeG1kZnY0bktzME9DWjFhbFgtenRSdkNkd0h3QWxXa0VGc0hQQmFFVWFhYmktQTA1SE5qdGgyRm5pblhnUVBTWU02cWN6ODBXY3dCUkJCQnpNSWJYR3BTZlZEblJrd0Y1MFZoYkYtT25WZGVlOHFmelJqRXB4Mmc?oc=5","date":"2025-12-16","type":"regulatory","source":"BioSpace","summary":"Pilatus Biosciences Announces FDA Clearance of IND Application for PLT012, a First-in-Class Anti-CD36 Metabolic Checkpoint Antibody in Solid Tumors - BioSpace","headline":"Pilatus Biosciences Announces FDA Clearance of IND Application for PLT012, a First-in-Class Anti-CD36 Metabolic Checkpoi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9CUWsyX3NkMFE1RVFxMkhiUG5VZXFJSFMxbkFhemhIS1JlNHNOOEk3bkt5U3lTZDRRNlFoWHlaSEd5VmpsSXd1ZlFDUWNnWkp4aWhR?oc=5","date":"2025-12-15","type":"trial","source":"FirstWord Pharma","summary":"Pilatus raises $14M to fund first-in-human study of anti-CD36 mAb - FirstWord Pharma","headline":"Pilatus raises $14M to fund first-in-human study of anti-CD36 mAb","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNRUUxaHBFanhXc2Q0ZmIxOW80dEZlZ0l0OG1rVEhVOHZXY3QxaWU5TkRLZWxoaFRYY0hiZG1jTllVcG84VVJDQVRzbE9pX1h6Q1ZsQlN6cXNEQlRwcUluRkNYcmVkV2dlQ1dDVU9yd21BaUJLSUktRkdmVzVSNkpkREZWbE1JY2V4MVlBcll3bFRDMFVlRTg1SE12SEJnMTdKU2xOdExfODNfRl9W?oc=5","date":"2025-08-14","type":"deal","source":"European Biotechnology Magazine","summary":"Pilatus Biosciences Enters Clinical Collaboration with Roche - European Biotechnology Magazine","headline":"Pilatus Biosciences Enters Clinical Collaboration with Roche","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxNQks3UjhrR1dhSWVmZC1XRno1U2xxN1ZTV1VyN2pKZ0dJSnM2VjJJdkNyMmZIaVNtdE1nOFpiZERobXdxNUJ0LVd4YUkyMkM0d2JYUjZpZTM3cXdxeTF3dE1hZ0huNU13OEVjdFlibWUxZDhJMlZiRXR3dXVJRzRWM0t1dDN3LTQyUDdPN3lGTHdaV2NzWTRwMnZZVnM2U24xcGFOclRSYmpYR3BjNzhQRE5kbGpZT1pUbzdwNFFzczh0RWRCbURVMzk4RDlNSm51UU1kQlp0Q0R5XzFXRFZyQzlzNWVKN3ZaNWpPNTlSME5TVHpfU3VQX3JGYkdPSzNMdERhd2J1YkR4azJqakRKZlMySDlWMGpCRUVmdlowUQ?oc=5","date":"2024-12-10","type":"regulatory","source":"PR Newswire","summary":"Pilatus Biosciences Inc. Secures FDA Orphan Drug Designation for PLT012: A Breakthrough in Liver and Intrahepatic Bile Duct Cancer Treatment - PR Newswire","headline":"Pilatus Biosciences Inc. Secures FDA Orphan Drug Designation for PLT012: A Breakthrough in Liver and Intrahepatic Bile D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9TMmJmZkZyMHFHY2VMWHBhQmRtSmN0cFRjdGg3OXdSSC11MV80eDFxSHBHcmhNSVZvMXFacVRQd1BvZ2kzdzZXc0dDWkt4ZUszd1FsWkkxX2QwaVI5OVN4MjVVc3NBbWtk?oc=5","date":"2024-09-05","type":"regulatory","source":"digitimes","summary":"Pilatus Biosciences makes breakthroughs in immunotherapy, demonstrating remarkable effectiveness in treating cancers with unmet medical needs - digitimes","headline":"Pilatus Biosciences makes breakthroughs in immunotherapy, demonstrating remarkable effectiveness in treating cancers wit","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}